Integral Diagnostics Ltd (ASX: IDX) Share Price and News

Mr Fay brings to the Board over 30 years of experience in funds and investment management, including Chief Executive Officer and Chief Investment Officer roles at Deutsche Asset Management (Australia) Limited. He also held a number of other senior investment roles at Deutsche Asset Management and previously at AMP Capital. He was a member of the Investment Board Committee of the Financial Services Council. Andrew is an experienced company director across ASX-listed, private and regulated entities and accordingly brings to the Board skills in financial and risk management, capital markets, executive remuneration frameworks, strategy, investment and corporate governance. Specifically, he has sector experience and expertise in financial services, including investment, funds, property and infrastructure management. He is Chair of the People, Culture Committee.

Ms Murphy, beginning her career in audit, has over 30 years of experience in strategic, financial and operational leadership in both industry and professional advisory. She was formerly a Partner in a national accounting firm, Managing Director of Korda Mentha and CEO of the Delta Group. In her professional advisory career, she specialised in operational and financial restructuring, with a particular emphasis on merger and acquisition integration across a range of significant public and private companies. She is Member of the Risk, Compliance and Sustainability Committee and Member of the People, Culture Committee.

Ms Player is an experienced former Executive and Non Executive Director with international commercial and regulatory experience in mergers and acquisitions, corporate governance, capital developments, risk and sustainability that spans different markets and industries in Australia and Europe. Her experience includes her senior executive roles with one of Australias leading healthcare providers, where she worked closely with the Board to deliver various capital raisings, retail listed notes, and debt finance deals. Her roles included Group Executive for Legal, Governance and Sustainability as well as General Counsel and Company Secretary. She is Chair of the Risk, Compliance and Sustainability Committee and Member of the People, Culture Committee.

Mr Hall healthcare executive leadership experience in Australia and New Zealand and is an experienced Board and Committee Chair. He was the Group CEO of St Vincents Health Australia, the second largest non government provider of hospital and care services in the country. He has also overseen multi site, for profit generating businesses at both board and executive levels in employment services, early learning services and aged care. He also has involvement in policy development at a federal level in Australia, having served on committees established by Prime Ministers, Deputy Prime Ministers, Health Ministers, Employment and Social Services Ministers. He is currently Non Executive Chair of For Purpose Aged Care, Non Executive Director of UNICEF Australia, a Director of Papua New Guinea Sustainable Development Fund and a trustee of Yajilarra. He is Member of the People, Culture Committee.

Dr Kadish began his career as a medical doctor in Johannesburg, South Africa. He followed with several roles overseas including McKinsey and Company, CSC Healthcare in New York City, and Netcare, a major hospital group in South Africa and the United Kingdom, where he was an Executive Director. His roles have included CEO and MD of Healthcare Australia, CEO and MD of Pulse Health Group and CEO of Laverty Pathology. He is Director of the Australian Diagnostic Imaging Association (ADIA). He is Member of the Integral Clinical Leadership Committee.

Ms McBain had been a Non Executive Director of Capitol. She is an experienced Executive and Non Executive Director with a strong background in the food, beverage, and consumer industries, specialising in brand development, fast growth, corporate governance, financial oversight, and business development. Her experience includes senior leadership roles as Managing Director at Bellamys Australia Limited and Maggie Beer Holdings Limited. She currently serves as a Non Executive Director at Tasmanian Irrigation Pty Ltd and the Tasmanian Devils AFL Club and is also a Director of the Australia China Business Council and President of its Tasmania Branch. In recognition of her leadership and contributions, she was named the 2013 Telstra Tasmanian Businesswoman of the Year and the Telstra Australian Businesswoman of the Year. She is Member of the Risk, Compliance and Sustainability Committee.

Dr Shaw had been a Non Executive Director of Capitol. He has sub specialty training in neuroradiology and musculoskeletal imaging. He is the current Director of Medical Imaging at Barwon Health. He is also a Clinical Professor at Deakin Medical School. He is a past examiner for the Royal Australian and New Zealand College of Radiologists (RANZCR) and previously sat on the Colleges Anatomy Exam Review Panel. He has been an MRI Clinical Reviewer for the College since 2014. Kevin currently sits on the Medical Advisory Committee, Technology/Clinical Practice Committee, and Mortality Committee at Barwon Health, as well as the Medical Imaging Advisory Board at Deakin University. He is a councilor for Australian Medical Association Victoria as the State Representative for RANZCR. He is Member of the Risk, Compliance and Sustainability Committee and Member of the People, Culture Committee.

Dr Mittal has a professional focus on MRI, including musculoskeletal, prostrate and cardiac imaging in addition to experience in neuroradiology and abdominal radiology. He also has experience in hospital settings including emergencies and trauma. He has held teaching roles at Melbourne University & Deakin University. He has worked within IDX and its precursor businesses for over 18 years and held senior clinical governance and leadership roles across a number of IDX business units which have enabled him to develop a deep understanding of the IDX operating businesses. He is Member of the Risk, Compliance and Sustainability Committee.

-

-

-